Search Our Medicine Executing on our mission to discover, develop, and deliver important new medicines to patients for the treatment of cancer. For patients and healthcare providers in the United States, you can learn more about QINLOCK (ripretinib) by visiting the product websites below or by accessing the prescribing information. U.S. PATIENTS WEBSITE U.S. HCP WEBSITE Highlights of Prescribing Information U.S. PRESCRIBING INFORMATION CANADA PRESCRIBING INFORMATION Personalized support and financial assistance for U.S. patients receiving QINLOCK. VISIT SITE twitter linkedin CONTACT US Main navigation Discovery Platform Pipeline Ripretinib Vimseltinib DCC-3116 Preclinical Pipeline Expanded Access Our Medicine QINLOCK® (ripretinib) Who We Are Management Board of Directors Join Us Open Positions Footer Utility Contact Us Terms of Use Privacy Policy Recruiting Privacy Policy Web Accessibility Statement © 2021 Deciphera Pharmaceuticals, Inc. QINLOCK and the QINLOCK logo are registered trademarks of Deciphera Pharmaceuticals, LLC. Deciphera and the Deciphera logo are trademarks of Deciphera Pharmaceuticals, LLC.